Givosiran Infusion 2.5 mg/kg IV infusion Suppliers & Bulk Manufacturers
Available Forms: Intravenous infusion
Available Strengths: 2.5 mg/kg IV infusion
Reference Brands: Givlaari
Category: Nanoemulsion/Nanoparticles
Givlaari (Givosiran) is an RNA interference therapy that reduces the production of hepatic aminolevulinic acid synthase 1 (ALAS1), decreasing neurovisceral attacks in acute hepatic porphyria. Benefits include fewer attacks, improved quality of life, and reduced hospitalization when administered regularly in specialized care settings.
Manufacture or export Givosiran Infusion? List it or send an offer →
Product Description:
Givlaari (Givosiran) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and quality manufacturing in line with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and pharmacovigilance. In the EU, approval is pending or granted in some countries, with CE marking certifying conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. Ensuring compliance guarantees access to effective Givosiran therapy supporting patients with hepatic porphyria worldwide.
Also known as: givosirán (Spanish), givosiran (Portuguese, French, Italian), Givosiran (German), جيفوسيران (Arabic), 吉沃西兰 (Chinese), ギボシラン (Japanese).
Givosiran Infusion — third party manufacturing & bulk supply
Givosiran Infusion 2.5 mg/kg IV infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Givosiran Infusion is supplied as Intravenous infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Givosiran Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Givosiran Infusion →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
El givosirán es un ARN pequeño de interferencia (siRNA) que reduce la producción hepática de las sustancias tóxicas implicadas en la porfiria hepática aguda, y está indicado para el tratamiento de esta enfermedad en adultos y adolescentes a partir de 12 años, según la ficha técnica. Se administra por vía subcutánea por un profesional sanitario, bajo la supervisión de un médico especialista. PharmaTradz ayuda a importadores, distribuidores y hospitales con licencia a obtener givosirán de fabricantes con certificación GMP.
O givosiran é um pequeno RNA de interferência (siRNA) que reduz a produção, no fígado, das substâncias tóxicas envolvidas na porfiria hepática aguda, e é indicado para o tratamento dessa doença em adultos e adolescentes a partir de 12 anos, conforme a bula. É administrado por via subcutânea por um profissional de saúde, sob supervisão de um médico especialista. A PharmaTradz ajuda importadores, distribuidores e hospitais licenciados a obter givosiran de fabricantes com certificação GMP.
Le givosiran est un petit ARN interférent (siRNA) qui réduit la production hépatique des substances toxiques impliquées dans la porphyrie hépatique aiguë ; il est indiqué dans le traitement de cette maladie chez l'adulte et l'adolescent à partir de 12 ans, selon le RCP. Il est administré par voie sous-cutanée par un professionnel de santé, sous la surveillance d'un médecin spécialiste. PharmaTradz aide les importateurs, distributeurs et hôpitaux agréés à obtenir du givosiran auprès de fabricants certifiés BPF (GMP).
Related Products
Patisiran Infusion
Strength:
0.3 mg/mL
Form: Intravenous (IV) infusion
Reference Brands: Onpattro
View Details
Covid-19 Vaccine
Strength:
30 µg per dose
Form: Vial for reconstitution (injectable, intramuscular)
Reference Brands: Comirnaty
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
